Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.PACB · Entity 5650 | Director | June 03, 2026 | June 04, 2026 |
| eHealth, Inc.EHTH · Entity 497 | Director | June 15, 2022 | June 17, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Report date June 03, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.58 · Expires 2036-06-03 | Direct | 223,492 |
Reported balance
After 2026-06-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-03 · Grant · Acquired 223,492 · Balance 223,492 F1: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates.
eHealth, Inc.
Report date June 15, 2022 · Filed June 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 63,338 |
Reported balance
After 2022-06-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-06-15 · Grant · Acquired 16,560 · Balance 63,338 F1: This represents an annual award of restricted stock units to the Company's non-employee directors. Each unit represents a contingent right to receive one share of the Company's common stock upon vesting. Subject to the Reporting Person's continuous service with the Company, the restricted stock units will become 100% vested on the day prior to the Company's next annual stockholder meeting approximately one year following the date of grant. The restricted stock units will also become 100% vested if the Company is subject to a change in control before the Reporting Person's service terminates. F2: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. |
Filing footnotes · ownership attribution and instrument terms
F1: This represents an annual award of restricted stock units to the Company's non-employee directors. Each unit represents a contingent right to receive one share of the Company's common stock upon vesting. Subject to the Reporting Person's continuous service with the Company, the restricted stock units will become 100% vested on the day prior to the Company's next annual stockholder meeting approximately one year following the date of grant. The restricted stock units will also become 100% vested if the Company is subject to a change in control before the Reporting Person's service terminates.
F2: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2026 Filed Jun 4, 2026 21:23 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 223,492 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001299130-26-000100 · wk-form4_1780608222.xml · derivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,492 Underlying: Common Stock · 223,492 shares Expires 2036-06-03 F1 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:10 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001299130-25-000137 · wk-form4_1749240605.xml · derivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2035-06-04 F1 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 20:53 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 32,179 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001299130-24-000150 · wk-form4_1718916796.xml · derivative · entry 2 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,179 Underlying: Common Stock · 32,179 shares Expires 2034-06-18 F2 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 20:53 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 22,821 | $0.00 | $0.00 |
DisclosureSEC source: 0001299130-24-000150 · wk-form4_1718916796.xml · nonDerivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,821 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest on the one (1) year anniversary of the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates. Read SEC document |
| May 24, 2023 Filed May 26, 2023 20:20 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 25,775 | $0.00 Strike: $11.94 | $0.00 |
DisclosureSEC source: 0001299130-23-000072 · wf-form4_168513237230116.xml · derivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,775 Underlying: Common Stock · 25,775 shares Expires 2033-05-24 F1 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:23 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 16,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-22-000080 · wf-form4_165550461552879.xml · nonDerivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,338 F1 · shares: This represents an annual award of restricted stock units to the Company's non-employee directors. Each unit represents a contingent right to receive one share of the Company's common stock upon vesting. Subject to the Reporting Person's continuous service with the Company, the restricted stock units will become 100% vested on the day prior to the Company's next annual stockholder meeting approximately one year following the date of grant. The restricted stock units will also become 100% vested if the Company is subject to a change in control before the Reporting Person's service terminates. F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| May 25, 2022 Filed May 27, 2022 23:24 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 63,015 | $0.00 Strike: $5.37 | $0.00 |
DisclosureSEC source: 0001299130-22-000079 · certent-form4.xml · derivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,015 Underlying: Common Stock · 63,015 shares Expires 2032-05-25 F1 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 23:48 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 3,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-21-000113 · wf-form4_162518327247948.xml · nonDerivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,778 F1 · shares: This represents an annual award of restricted stock units to the Company's non-employee directors. Each unit represents a contingent right to receive one share of the Company's common stock upon vesting. Subject to the Reporting Person's continuous service with the Company, the restricted stock units will become 100% vested on the day prior to the Company's next annual stockholder meeting approximately one year following the date of grant. The restricted stock units will also become 100% vested if the Company is subject to a change in control before the Reporting Person's service terminates. F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| June 16, 2021 Filed Jun 22, 2021 01:17 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 12,885 | $0.00 Strike: $27.90 | $0.00 |
DisclosureSEC source: 0001299130-21-000174 · certent-form4.xml · derivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,885 Underlying: Common Stock · 12,885 shares Expires 2031-06-16 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, or, if earlier, on the date of the next annual meeting of stockholders, provided the Reporting Person continues to serve as a director through each vesting date. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 02:17 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001299130-21-000053 · certent-form4.xml · derivative · entry 7 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2023-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 02:17 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001299130-21-000053 · certent-form4.xml · derivative · entry 6 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2022-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 02:17 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionStock Option (right to buy) · Derivative | 17,500 | $0.00 Strike: $10.58 | $0.00 |
DisclosureSEC source: 0001299130-21-000053 · certent-form4.xml · derivative · entry 5 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,500 shares Expires 2021-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 02:17 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 67,500 | $48.07 | $3,244,455.00 |
DisclosureSEC source: 0001299130-21-000053 · certent-form4.xml · nonDerivative · entry 4 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: This sale price represents the weighted average sale price of the shares sold ranging from $48.00 to $48.70 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 02:17 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionCommon Stock | 25,000 | $2.54 | $63,500.00 |
DisclosureSEC source: 0001299130-21-000053 · certent-form4.xml · nonDerivative · entry 3 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 02:17 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionCommon Stock | 25,000 | $1.83 | $45,750.00 |
DisclosureSEC source: 0001299130-21-000053 · certent-form4.xml · nonDerivative · entry 2 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 02:17 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionCommon Stock | 17,500 | $10.58 | $185,150.00 |
DisclosureSEC source: 0001299130-21-000053 · certent-form4.xml · nonDerivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 22:45 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 97,785 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0001209191-20-045570 · doc4.xml · derivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,785 Underlying: Common Stock · 97,785 shares Expires 2030-08-04 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, or if earlier, on the date of the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director through each vesting date. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 20:21 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 1,631 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-20-000106 · wf-form4_159190687502948.xml · nonDerivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,557 F1 · shares: This represents an annual award of restricted stock units to the Company's non-employee directors. Each unit represents a contingent right to receive one share of the Company's common stock upon vesting. Subject to the Reporting Person's continuous service with the Company, the restricted stock units will become 100% vested on the day prior to the Company's next annual stockholder meeting approximately one year following the date of grant. The restricted stock units will also become 100% vested if the Company is subject to a change in control before the Reporting Person's service terminates. F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:14 UTC | eHealth, Inc. EHTH · Entity 497 | SaleCommon Stock | 59 | $128.20 | $7,563.80 |
DisclosureSEC source: 0001333493-20-000085 · wf-form4_159130522358699.xml · nonDerivative · entry 3 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,926 F1 · kind: The transaction reported on this date was effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Table I, Column 4 for sales on 6/2/2020 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.20 to $128.21, inclusive. F3 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:14 UTC | eHealth, Inc. EHTH · Entity 497 | SaleCommon Stock | 4,941 | $127.88 | $631,855.08 |
DisclosureSEC source: 0001333493-20-000085 · wf-form4_159130522358699.xml · nonDerivative · entry 2 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,985 F1 · kind: The transaction reported on this date was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Table I, Column 4 for sales on 6/2/2020 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.18 to $128.15, inclusive. F3 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:14 UTC | eHealth, Inc. EHTH · Entity 497 | SaleCommon Stock | 5,000 | $130.00 | $650,000.00 |
DisclosureSEC source: 0001333493-20-000085 · wf-form4_159130522358699.xml · nonDerivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,926 F1 · kind: The transaction reported on this date was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Table I, Column 4 for sales on 6/2/2020 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.00 to $130.07, inclusive. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 4 and 5 of this Form 4. F3 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 01:29 UTC | eHealth, Inc. EHTH · Entity 497 | SaleCommon Stock | 735 | $105.11 | $77,255.85 |
DisclosureSEC source: 0001333493-19-000105 · wf-form4_156470932696074.xml · nonDerivative · entry 5 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,926 F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Table I, Column 4 for sales on 8/1/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.89 to $105.37, inclusive. F3 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 01:29 UTC | eHealth, Inc. EHTH · Entity 497 | SaleCommon Stock | 2,000 | $104.13 | $208,260.00 |
DisclosureSEC source: 0001333493-19-000105 · wf-form4_156470932696074.xml · nonDerivative · entry 4 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,661 F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Table I, Column 4 for sales on 8/1/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.85 to $104.62, inclusive. F3 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 01:29 UTC | eHealth, Inc. EHTH · Entity 497 | SaleCommon Stock | 2,437 | $103.27 | $251,668.99 |
DisclosureSEC source: 0001333493-19-000105 · wf-form4_156470932696074.xml · nonDerivative · entry 3 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,661 F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Table I, Column 4 for sales on 8/1/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.84 to $103.78, inclusive. F3 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 01:29 UTC | eHealth, Inc. EHTH · Entity 497 | SaleCommon Stock | 8,267 | $102.18 | $844,722.06 |
DisclosureSEC source: 0001333493-19-000105 · wf-form4_156470932696074.xml · nonDerivative · entry 2 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,098 F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Table I, Column 4 for sales on 8/1/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.74 to $102.71, inclusive. F3 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 01:29 UTC | eHealth, Inc. EHTH · Entity 497 | SaleCommon Stock | 1,561 | $101.19 | $157,961.34 |
DisclosureSEC source: 0001333493-19-000105 · wf-form4_156470932696074.xml · nonDerivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,365 F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Table I, Column 4 for sales on 8/1/2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.73 to $101.74, inclusive. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7) of this Form 4. F3 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 19:46 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 2,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-19-000068 · wf-form4_156045516358751.xml · nonDerivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,926 F1 · shares: This represents an annual award of restricted stock units to the Company's non-employee directors. Each unit represents a contingent right to receive one share of the Company's common stock upon vesting. Subject to the Reporting Person's continuous service with the Company, the restricted stock units will become 100% vested on the day prior to the Company's next annual stockholder meeting approximately one year following the date of grant. The restricted stock units will also become 100% vested if the Company is subject to a change in control before the Reporting Person's service terminates. F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 20:03 UTC | eHealth, Inc. EHTH · Entity 497 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $12.20 | $0.00 |
DisclosureSEC source: 0001333493-18-000136 · wf-form4_153332657830172.xml · derivative · entry 9 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2020-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: Immediately exercisable for all shares subject to the option. The option vested as to 100% of the shares on the day prior to the Company's annual stockholder meeting approximately one year following the grant date. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 20:03 UTC | eHealth, Inc. EHTH · Entity 497 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,250 | $0.00 Strike: $17.76 | $0.00 |
DisclosureSEC source: 0001333493-18-000136 · wf-form4_153332657830172.xml · derivative · entry 8 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,250 shares Expires 2019-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: Immediately exercisable for all shares subject to the option. The option vested as to 100% of the shares on the day prior to the Company's annual stockholder meeting approximately one year following the grant date. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 20:03 UTC | eHealth, Inc. EHTH · Entity 497 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $12.40 | $0.00 |
DisclosureSEC source: 0001333493-18-000136 · wf-form4_153332657830172.xml · derivative · entry 7 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2018-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: Immediately exercisable for all shares subject to the option. The option vested as to 25% of the shares one year after December 17, 2008 and 1/48th of the shares upon completion of each month of continuous service thereafter. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 20:03 UTC | eHealth, Inc. EHTH · Entity 497 | SaleCommon Stock | 7,500 | $25.00 | $187,500.00 |
DisclosureSEC source: 0001333493-18-000136 · wf-form4_153332657830172.xml · nonDerivative · entry 6 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,704 F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 20:03 UTC | eHealth, Inc. EHTH · Entity 497 | Exercise / conversionCommon Stock | 7,500 | $12.20 | $91,500.00 |
DisclosureSEC source: 0001333493-18-000136 · wf-form4_153332657830172.xml · nonDerivative · entry 5 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 20:03 UTC | eHealth, Inc. EHTH · Entity 497 | SaleCommon Stock | 3,250 | $25.00 | $81,250.00 |
DisclosureSEC source: 0001333493-18-000136 · wf-form4_153332657830172.xml · nonDerivative · entry 4 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,704 F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 20:03 UTC | eHealth, Inc. EHTH · Entity 497 | Exercise / conversionCommon Stock | 3,250 | $17.76 | $57,720.00 |
DisclosureSEC source: 0001333493-18-000136 · wf-form4_153332657830172.xml · nonDerivative · entry 3 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,954 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 20:03 UTC | eHealth, Inc. EHTH · Entity 497 | SaleCommon Stock | 10,000 | $25.00 | $250,000.00 |
DisclosureSEC source: 0001333493-18-000136 · wf-form4_153332657830172.xml · nonDerivative · entry 2 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,704 F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 20:03 UTC | eHealth, Inc. EHTH · Entity 497 | Exercise / conversionCommon Stock | 10,000 | $12.40 | $124,000.00 |
DisclosureSEC source: 0001333493-18-000136 · wf-form4_153332657830172.xml · nonDerivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 18:25 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 7,262 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-18-000119 · wf-form4_152900069707450.xml · nonDerivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,704 F1 · kind: This represents an annual award of restricted stock units to the Company's non-employee directors. Each unit represents a contingent right to receive one share of the Company's common stock upon vesting. Subject to the Reporting Person's continuous service with the Company, the restricted stock units will become 100% vested on the day prior to the Company's next annual stockholder meeting approximately one year following the date of grant. The restricted stock units will also become 100% vested if the Company is subject to a change in control before the Reporting Person's service terminates. F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| May 22, 2018 Filed May 23, 2018 20:18 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.61 | $0.00 |
DisclosureSEC source: 0001209191-18-032584 · doc4.xml · derivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-05-22 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 19:09 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 8,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-17-000081 · edgar.xml · nonDerivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,442 F1 · kind: This represents an annual award of restricted stock units to the Company's non-employee directors. Each unit represents a contingent right to recieve one share of the Company's common stock upon vesting. Subject to the Reporting Person's continuous service with the Company, the restricted stock units will become 100% vested on the day prior to the Company's next annual stockholder meeting approximately one year following the date of grant. The restricted stock units will also become 100% vested if the Company is subject to change in control before the Reporting Person's service terminates. F2 · balance_after: Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election. Read SEC document |
| May 24, 2017 Filed May 25, 2017 21:27 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.81 | $0.00 |
DisclosureSEC source: 0001209191-17-035511 · doc4.xml · derivative · entry 1 LIVINGSTON RANDALL S · CIK 0001235118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-05-24 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.